STERIS (Ireland) Cash Flow Statement
NYSE: STEHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
STERIS (Ireland) free cash flow
In fiscal 2026, STERIS (Ireland) generated $1.34 billion of operating cash flow and spent $369.0 million on capital expenditures. That left free cash flow of $972.4 million, a free-cash-flow margin of 16.4% of revenue. Free cash flow was up 25.0% from the prior year's $778.0 million.
STERIS (Ireland) returned $477.3 million to shareholders: $241.8 million in dividends and $235.5 million in share repurchases, equal to 49% of free cash flow. Free cash flow covered dividend payments 4.0 times.
Summary generated from market data by MetaCap's automated system. Methodology
STERIS (Ireland) cash flow statement (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 | FY 20172017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 785.10M | 616.10M | 380.10M | 105.81M | 242.87M | 396.87M | 407.86M | 304.75M | 291.62M | 110.63M |
| Net Income growth (YoY) | +27.43% | +62.09% | +259.22% | -56.43% | -38.80% | -2.69% | +33.84% | +4.50% | +163.60% | — |
| Depreciation & Amortization | 486.50M | 476.20M | 565.20M | 552.90M | 553.10M | 219.24M | 197.24M | 225.92M | 178.33M | 188.14M |
| Stock-Based Compensation | 61.70M | 57.40M | 56.50M | 38.95M | 57.66M | 25.97M | 23.81M | 23.96M | 22.19M | 18.79M |
| Change in Working Capital | 27.10M | 66.50M | -146.20M | -250.02M | -149.28M | 19.01M | -49.81M | 10.34M | -59.15M | -57.20M |
| Operating Cash Flow | 1.34B | 1.15B | 973.30M | 756.95M | 684.81M | 689.64M | 590.56M | 539.50M | 457.63M | 424.09M |
| Capital Expenditures | -369.00M | -370.10M | -360.30M | -361.97M | -287.56M | -239.26M | -214.52M | -189.72M | -165.46M | -172.90M |
| Investing Cash Flow | -512.50M | 388.80M | -887.40M | -383.33M | -666.56M | -1.15B | -319.74M | -213.22M | -203.83M | -104.25M |
| Dividends Paid | -241.80M | -219.90M | -200.60M | -183.50M | -163.17M | -133.84M | -123.03M | -112.50M | -102.93M | -93.19M |
| Share Repurchases | -235.50M | -211.30M | -11.80M | -308.56M | -55.78M | -14.65M | -51.24M | -81.49M | -65.48M | -97.51M |
| Debt Issued | — | — | 0 | 0 | 650.00M | 550.00M | 0 | 0 | — | — |
| Debt Repaid | — | — | — | — | — | -35.00M | 0 | -85.00M | -222.50M | -172.50M |
| Financing Cash Flow | -568.20M | -1.57B | -85.20M | -498.72M | 115.83M | 345.62M | -163.15M | -294.79M | -356.18M | -267.10M |
| Net Change in Cash | 267.90M | -35.30M | -1.30M | -139.96M | 127.79M | -99.05M | 98.95M | 19.10M | -81.38M | 34.08M |
| Free Cash Flow | 972.40M | 778.00M | 613.00M | 394.98M | 397.25M | 450.38M | 376.04M | 349.79M | 292.18M | 251.19M |
This table shows 10 annual periods of STERIS (Ireland)'s cash flow statement, from FY 2026 back to FY 2017, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow STE's reporting calendar. What is a cash flow statement?